Cointime

Genekine

company

About

Genekine is a biotechnology enterprise focusing on the research and development of macromolecular drugs.

Highlights

Funding Rounds
1
Investors
2

Details

Last Funding Type
Funding Round
Industries
Biotechnology,Health Care,Product Research
Founded date
Nov 1, 2012
Operating Status
Active

Genekine is a biotechnology enterprise focusing on the research and development of macromolecular drugs. Genekine conducts research and industrialization of new protein expression systems based on genetic engineering, protein engineering and glycoengineering, and other related biotechnologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
Genekine has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 27, 2018 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 27, 2018 Funding Round — 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Genekine is funded by 2 investors. Zhejiang Business Chanrong Holding and PH Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Zhejiang Business Chanrong Holding — Funding Round
PH Capital — Funding Round
Cointime
เนื้อหา
บริษัท